JP2014534227A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534227A5 JP2014534227A5 JP2014540047A JP2014540047A JP2014534227A5 JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5 JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- moiety
- compound according
- linker
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553854P | 2011-10-31 | 2011-10-31 | |
| US61/553,854 | 2011-10-31 | ||
| PCT/US2012/062850 WO2013151584A1 (en) | 2011-10-31 | 2012-10-31 | Compound comprising a mao targeting/ seeker moiety for treating human gliomas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534227A JP2014534227A (ja) | 2014-12-18 |
| JP2014534227A5 true JP2014534227A5 (cg-RX-API-DMAC7.html) | 2015-11-12 |
| JP6118808B2 JP6118808B2 (ja) | 2017-04-19 |
Family
ID=47146760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540047A Expired - Fee Related JP6118808B2 (ja) | 2011-10-31 | 2012-10-31 | ヒトグリオームを治療するためのｍａｏ標的化／探索部分を含む化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10555936B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2804604A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6118808B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102110794B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104136026B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012376221A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2887928A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1204547A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013151584A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012376221A1 (en) | 2011-10-31 | 2014-06-19 | David S. Baskin | Compound comprising a MAO targeting/ seeker moiety for treating human gliomas |
| CN104710433B (zh) * | 2014-01-23 | 2016-08-17 | 南京友怡医药科技有限公司 | 苯丁酸氮芥衍生物、制备方法及应用 |
| US10807944B2 (en) * | 2014-04-04 | 2020-10-20 | University Of Florida Research Foundation, Inc. | HDAC inhibitor compounds and methods of treatment |
| US12245355B2 (en) | 2021-02-19 | 2025-03-04 | Mevion Medical Systems, Inc. | Gantry for a particle therapy system |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4913891A (en) * | 1986-04-17 | 1990-04-03 | The United States Of America As Represented By The United States Department Of Energy | Positron emitter labeled enzyme inhibitors |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| AU7244894A (en) * | 1993-06-07 | 1995-01-03 | Wellcome Foundation Limited, The | Immunoreactive reagents employing monoamine oxidase |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US5612329A (en) | 1995-06-05 | 1997-03-18 | University Of Maryland At Baltimore | Diaziridinylpolyamine anti-cancer agents |
| WO1998022110A1 (en) * | 1996-11-20 | 1998-05-28 | Virginia Tech Intellectual Properties, Inc. | Prodrugs for the selective inhibition of monoamine oxidase-b |
| JP2002538136A (ja) | 1999-03-03 | 2002-11-12 | ザ プロクター アンド ギャンブル カンパニー | アルケニルおよびアルキニル含有メタロプロテアーゼ阻害剤 |
| EP1334139A2 (en) | 2000-11-07 | 2003-08-13 | Symyx Technologies, Inc. | Substituted pyridyl amine ligands, complexes and catalysts therefrom. processes for producing polyolefins therewith |
| US6946479B2 (en) | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| WO2004110255A2 (en) | 2003-06-09 | 2004-12-23 | Gang Zheng | Antineoplastic agents targeted via glut transporters |
| BRPI0510963A (pt) * | 2004-05-14 | 2007-11-20 | Pfizer Prod Inc | derivados pirimidina para o tratamento do crescimento anormal de células |
| US7091205B2 (en) | 2004-10-08 | 2006-08-15 | Yu Show Fu | Use of tetramethylpyrazine in the treatment of brain tumor |
| GB0513297D0 (en) | 2005-06-29 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| US20070275944A1 (en) | 2006-04-05 | 2007-11-29 | The Board Of Trustees Operating Michigan State University | Antioxidants and methods of their use |
| AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
| EP2265608A2 (en) * | 2008-02-29 | 2010-12-29 | Array Biopharma, Inc. | Raf inhibitor compounds and methods of use thereof |
| EP2141163A1 (de) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
| RS58855B1 (sr) * | 2009-06-10 | 2019-07-31 | Chugai Pharmaceutical Co Ltd | Tetraciklična jedinjenja |
| ES2528948T3 (es) * | 2009-09-21 | 2015-02-13 | Chemocentryx, Inc. | Derivados de pirrolidinona carboxamida como moduladores de quemerina-R (ChemR23) |
| AU2012376221A1 (en) | 2011-10-31 | 2014-06-19 | David S. Baskin | Compound comprising a MAO targeting/ seeker moiety for treating human gliomas |
-
2012
- 2012-10-31 AU AU2012376221A patent/AU2012376221A1/en not_active Abandoned
- 2012-10-31 WO PCT/US2012/062850 patent/WO2013151584A1/en not_active Ceased
- 2012-10-31 CA CA2887928A patent/CA2887928A1/en not_active Abandoned
- 2012-10-31 CN CN201280064763.1A patent/CN104136026B/zh not_active Expired - Fee Related
- 2012-10-31 EP EP12783818.3A patent/EP2804604A1/en not_active Withdrawn
- 2012-10-31 KR KR1020147014835A patent/KR102110794B1/ko active Active
- 2012-10-31 EP EP20189611.5A patent/EP3815685A3/en not_active Withdrawn
- 2012-10-31 HK HK15103179.0A patent/HK1204547A1/xx unknown
- 2012-10-31 JP JP2014540047A patent/JP6118808B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-30 US US14/266,729 patent/US10555936B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102123365B1 (ko) | 항박테리아 치료제 및 예방제 | |
| US20190167676A1 (en) | Methods for improving resistance to skeletal muscle fatigue | |
| US20170157168A1 (en) | Prevention of gastric ulcer by carbon monoxide | |
| US8299033B2 (en) | Iodo-hexose compounds useful to treat cancer | |
| JP2011529474A (ja) | ｃｄｋ阻害剤および抗悪性腫瘍剤を含む治療用組合せ | |
| JP2018048178A (ja) | オキサビシクロヘプタン類、および再灌流障害の治療のためのオキサビシクロヘプタン類 | |
| JP2010523696A (ja) | 脳腫瘍を治療する方法 | |
| TW201244714A (en) | PARP inhibitors for the treatment of CIPN | |
| US20200179417A1 (en) | Combination chemotherapies | |
| JP2014534227A5 (cg-RX-API-DMAC7.html) | ||
| RU2011151861A (ru) | Оксазолидинонсодержащие димерные соединения, композиции и способы их получения и использования | |
| JP2013504590A (ja) | 非放射性リン脂質化合物、組成物、及び使用方法 | |
| WO2019079297A1 (en) | COMPOUNDS AND METHODS OF TREATING CANCER | |
| JP2019523783A (ja) | がんの治療に有用なポルフィリン化合物及び組成物 | |
| EP3011972A1 (en) | Medicinal composition for promoting synthesis of protoporphyrin ix | |
| TW201309298A (zh) | 治療惡性神經膠質瘤之醫藥組合物 | |
| Friedman et al. | Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts | |
| CN104136026B (zh) | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 | |
| AU2017235350B2 (en) | Combination therapy for proliferative diseases | |
| WO2018222134A1 (en) | Cancer therapy | |
| CA3115103A1 (en) | Pi3k inhibitors and uses thereof | |
| US20100087398A1 (en) | Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions | |
| RU2639819C2 (ru) | Композиция, ингибирующая теломеразу | |
| JP2019131508A (ja) | ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法 | |
| KR20240144944A (ko) | 항종양제와 관련된 질병 또는 증상을 예방하거나 치료하는 방법 |